Mr, Speaker, this is a very important question. The issue with respect to the regulations is simply to ensure the 20 year patent protection period afforded not just pharmaceutical products but all patents is neither more nor less than 20 years.
The industry committee heard evidence from some who said it caused an extension of the period and from others who said it was not effective in giving 20 year protection. Any changes we make will be intended simply and clearly to ensure that 20 years is it. No more, no less.